Schlosser Michael J

SEC Form 4 insider
EVP and Chief Clinical Officer · HCA Healthcare, Inc. ($HCA)
1 thesis · first seen Nov 2, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d1100%+2.0%+2.0%
1w000———
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$HCASEC Form 4bearish
Sold 1,200 @ $494.65 avg · $593,583 · 2026-11-04

Form 4: Schlosser Michael J sold HCA

Schlosser Michael J (EVP and Chief Clinical Officer at HCA Healthcare, Inc.) reported an open-market sale of 1,200 shares of HCA at an average $494.65, roughly $593,583, in a Form 4 filed 2026-11-06.

At post $494.99Now $504.42+1.9% since postedas of Nov 10, 4:45 PM ET
1d—
3d+2.0%
1w—
1m—
3m—
6m—
1y—
View filing on SEC.gov →

End of results.